Chief Executive Officer & Chairman, Bristol-Myers Squibb Company
Most recently reported pay: $5.8M. No year-by-year proxy breakdown is on file — common for foreign private issuers and recently listed companies, which do not file a US proxy statement.
Names, titles and pay as reported by the company and its SEC filings, via Financial Modeling Prep. Reference only — nothing here is investment advice, and no affiliation with or endorsement by the people listed is implied.
Should You Buy Bristol Myers Squibb Stock Right Now for the Yield Alone?
Sep 13, 2026https://www.fool.com/investing/2026/09/13/should-you-buy-bristol-myers-squibb-stock-yield/sentiment +0.80
How Much Do You Really Need Invested in Bristol Myers Squibb to Collect $10,000 a Year?
Sep 12, 2026https://247wallst.com/investing/2026/09/12/how-much-do-you-really-need-invested-in-bristol-myers-squibb-to-collect-10000-a-year/sentiment -0.20
Bristol Myers Squibb's Breakout Is Here: Portfolio Renewal Gaining Momentum
Sep 5, 2026https://seekingalpha.com/article/4943316-bristol-myers-squibbs-breakout-is-here-portfolio-renewal-gaining-momentumsentiment +0.80
Will Camzyos' Long-Term Benefits Strengthen BMY's Growth Outlook?
Sep 4, 2026https://www.zacks.com/stock/news/2985466/will-camzyos-long-term-benefits-strengthen-bmy-s-growth-outlook?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2985466sentiment +0.90
Merck Stock Hits New 52-Week High: What's Driving the Rally?
Aug 26, 2026https://www.zacks.com/stock/news/2980276/merck-stock-hits-new-52-week-high-what-s-driving-the-rally?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2980276sentiment -0.20
BioNTech präsentiert auf der WCLC 2026 Fortschritte ihrer spätklinischen Pipeline bei Lungenkrebs und erste globale Daten zur innovativen Behandlungskombination aus Pumitamig und Elfetabart Drozuntecan
Aug 20, 2026https://www.globenewswire.com/news-release/2026/08/20/3348151/0/de/biontech-pr%c3%a4sentiert-auf-der-wclc-2026-fortschritte-ihrer-sp%c3%a4tklinischen-pipeline-bei-lungenkrebs-und-erste-globale-daten-zur-innovativen-behandlungskombination-aus-pumitamig-und-e.htmlsentiment +0.40
